Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause Dermatitis exfoliative generalised? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Dermatitis exfoliative generalised have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.

16
Reports of Dermatitis exfoliative generalised with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
0
Deaths
9
Hospitalizations

How Dangerous Is Dermatitis exfoliative generalised From SITAGLIPTIN?

Of the 16 reports, 9 (56.3%) required hospitalization, and 2 (12.5%) were considered life-threatening.

Is Dermatitis exfoliative generalised Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause Dermatitis exfoliative generalised?

ALLOPURINOL (192) DUPILUMAB (162) METHOTREXATE (151) SULFAMETHOXAZOLE\TRIMETHOPRIM (140) AMOXICILLIN (122) ADALIMUMAB (113) PANTOPRAZOLE (105) SECUKINUMAB (96) VANCOMYCIN (92) AMLODIPINE (91)

Which SITAGLIPTIN Alternatives Have Lower Dermatitis exfoliative generalised Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All Dermatitis exfoliative generalised Reports All Drugs Causing Dermatitis exfoliative generalised SITAGLIPTIN Demographics